Cholinergic-adrenergic antagonism in the induction of tachyarrhythmia by electrical stimulation in isolated rat atria

Journal of Molecular and Cellular Cardiology
Nivaldo ZafalonRosana A Bassani

Abstract

Atrial tachyarrhythmias (AT) are the most common cardiac rhythm disturbance. In the present study, we analyzed the cholinergic-adrenergic interaction in the in vitro induction of cholinergic-dependent tachyarrhythmia by high-frequency electric stimulation. Tachyarrhythmia was evoked in isolated rat right atria by trains of electric stimuli. Atrial response was expressed as the tachyarrhythmia induction index (ATI, i.e. the fraction of applied trains that resulted in arrhythmia induction). ATI was reversibly increased by 0.6 microM carbachol (CCh), which also decreased atrial spontaneous rate (ASR). In contrast, 10 nM isoproterenol (ISO), 100 microM tyramine and the phosphodiesterase inhibitor isobutyl-methylxanthine (IBMX, 100 microM) increased ASR and decreased ATI. Amiodarone (AMI, 10 microM) reduced ATI in the presence and absence of CCh. Further CCh addition restored ATI in atria treated with either IBMX or AMI, but not when both compounds were present. Increase in ATI by CCh in atria pretreated with IBMX plus ISO was significantly attenuated by 3 mM NaF. The antagonism between cholinergic muscarinic and beta-adrenergic receptor stimulation (the former facilitating and the latter inhibiting tachyarrhythmia installation) pos...Continue Reading

References

Sep 1, 1992·British Journal of Pharmacology·T BethkeH Wenzlaff
Mar 1, 1988·Journal of Cardiovascular Pharmacology·D E Euler, P J Scanlon
Jan 1, 1987·Journal of Molecular and Cellular Cardiology·J W FlemingA M Watanabe
Sep 1, 1974·Cardiovascular Research·D P ZipesG T Robbins
Feb 1, 1996·Pacing and Clinical Electrophysiology : PACE·L A GeddesG M Ayers
Oct 1, 1996·Stroke; a Journal of Cerebral Circulation·H J LinR B D'Agostino
Oct 23, 1997·Circulation·B M PsatyP M Rautaharju
Sep 11, 1998·The American Journal of Cardiology·K SeidlJ Senges
Aug 13, 1999·Journal of Cardiovascular Pharmacology·R SakaiA J Pappano
Oct 8, 1999·Journal of Cardiovascular Pharmacology·C M GodoyJ W Bassani
Feb 7, 2001·Circulation·M A AllessieA L Waldo
Jun 23, 2001·Journal of the American College of Cardiology·P KovoorD E Clapham
Jan 15, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Josef GehrmannUlrike Mende
May 28, 2002·Journal of Cardiovascular Electrophysiology·Henggui ZhangMark R Boyett
May 30, 2002·Journal of Cardiovascular Electrophysiology·Eugene A SosunovMichael R Rosen
Jan 4, 2003·Journal of the National Medical Association·David DangL Julian Haywood
Jun 5, 2003·Journal of Cardiovascular Electrophysiology·Simon P FynnClifford J Garratt
Nov 24, 1956·Nature·E A JOHNSON, M G MCKINNON
Dec 4, 1958·The Journal of Physiology·J H BURN, M J RAND

❮ Previous
Next ❯

Citations

May 25, 2011·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Anderson J FerreiraAlvair P Almeida
Oct 14, 2009·Physiological Measurement·Nivaldo ZafalonRosana A Bassani

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.